Deutsche Bank’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-114,846
| Closed | -$305K | – | 3708 |
|
|
2024
Q1 | $305K | Hold |
114,846
| – | – | ﹤0.01% | 2558 |
|
|
2023
Q4 | $272K | Hold |
114,846
| – | – | ﹤0.01% | 2659 |
|
|
2023
Q3 | $161K | Hold |
114,846
| – | – | ﹤0.01% | 2896 |
|
|
2023
Q2 | $348K | Sell |
114,846
-18,034
| -14% | -$54.6K | ﹤0.01% | 2553 |
|
|
2023
Q1 | $831K | Buy |
132,880
+1,930
| +1% | +$12.1K | ﹤0.01% | 2208 |
|
|
2022
Q4 | $799K | Buy |
130,950
+196
| +0.1% | +$1.2K | ﹤0.01% | 2181 |
|
|
2022
Q3 | $1.56M | Sell |
130,754
-1,951
| -1% | -$23.3K | ﹤0.01% | 1725 |
|
|
2022
Q2 | $1.67M | Buy |
132,705
+667
| +0.5% | +$8.41K | ﹤0.01% | 1862 |
|
|
2022
Q1 | $1.49M | Sell |
132,038
-1,658
| -1% | -$18.7K | ﹤0.01% | 2072 |
|
|
2021
Q4 | $2.37M | Buy |
133,696
+830
| +0.6% | +$14.7K | ﹤0.01% | 1882 |
|
|
2021
Q3 | $3.06M | Buy |
132,866
+6,555
| +5% | +$151K | ﹤0.01% | 1788 |
|
|
2021
Q2 | $2.94M | Buy |
126,311
+99,184
| +366% | +$2.31M | ﹤0.01% | 1882 |
|
|
2021
Q1 | $845K | Buy |
+27,127
| New | +$845K | ﹤0.01% | 2757 |
|